Status:
NOT_YET_RECRUITING
Comparison Between Haparin and Herodin in HD
Lead Sponsor:
Basma Rabiey
Conditions:
Haemodialysis
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is: which drug is more safe in Haemodialysis?
Detailed Description
Extracorporeal thrombogenesis is a major problem associated with haemodialysis. The composition of the artificial membrane in the extracorporial system and large surface area to which the blood is exp...
Eligibility Criteria
Inclusion
- patient age between 18:70
- Haemodialysis duration less than 6 months
- Agree to participate in the study
Exclusion
- AKI
- patients with impaired coagulation profile
- Decompensated liver disease
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT06112262
Start Date
December 20 2023
End Date
September 1 2026
Last Update
November 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.